Cite
HARVARD Citation
Kim, Y. et al. (2021). Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis. European journal of cancer. pp. 411-421. [Online].